MELLETT PAUL J
SEC insider (Form 3/4/5 filer). CIK 0001185034. Chief Fin. & Admin Officer at ENANTA PHARMACEUTICALS INC (ENTA). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2025. Located in WATERTOWN, MA.
Companies MELLETT PAUL J has filed insider reports for
- ENANTA PHARMACEUTICALS INC (ENTA): Officer, Chief Fin. & Admin Officer
MELLETT PAUL J
CIK: 0001185034
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENTA
ENANTA PHARMACEUTICALS INC
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect7.5K shares- - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect3.3K shares at avg. $5.59$19K - Dec 6, 2024ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect2.6K shares at avg. $8.06$21K - Dec 1, 2024ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect1.6K shares at avg. $8.60$14K - Nov 27, 2024ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
81K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award | 7,500 | - | - | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 3,326 | $5.59 | $18,592 | Direct |
| Dec 6, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 2,591 | $8.06 | $20,883 | Direct |
| Dec 1, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 1,595 | $8.60 | $13,717 | Direct |
| Nov 27, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 81,000 | - | - | Direct |
1-5 of 5 transactions